Table 3 Multivariate analyses of factors associated with recurrence-free survival and overall survival

From: ASPP2 inhibits tumor growth by repressing the mevalonate pathway in hepatocellular carcinoma

 

Hazard ratio (95% CI)

P

RFS

 Tumor size, cm (≥5 vs. <5)

2.530 (1.355–4.725)

0.004

 ASPP2 (high vs. low)

0.505 (0.257–0.989)

0.026

 HMGCR (high vs. low)

2.182 (1.147–4.150)

0.017

OS

 Tumor size, cm (≥5 vs. <5)

2.103 (1.122–3.942)

0.02

 ASPP2 (high vs. low)

0.453 (0.235–0.873)

0.017

 HMGCR (high vs. low)

2.530 (1.355–4.725)

0.004

  1. Multivariate analysis, cox proportional hazards regression model
  2. Variables were adopted for their prognostic significance by univariate analysis and no obvious correlation between each other